The legal battle between Daiichi and former Ranbaxy promoters Malvinder and Shivinder Singh does not seem to be reaching an end. The Japanese drug maker has now approached the Delhi High Court to stop the sale of Fortis Healthcare to Manipal Health Enterprises.